Future direction of neoadjuvant therapy for breast cancer.
Valero
V
V
Department of Breast Medical Oncology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D017024:Chemotherapy, Adjuvant / Q000639:trends; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D017978:Receptors, Growth Factor / Q000187:drug effects
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D007155:Immunologic Factors; D017978:Receptors, Growth Factor